The Journal of Antibiotics · 2001 · 24 citations · 10 references
Life SciencesBiochemistryMicrobiologyMicrobial MetabolismCell Wall BiosynthesisGlycan BiosynthesisGlycosylation PathwaysMicrobial Natural Product BiosynthesisBacterial Cell Wall BiosynthesisBacterial Cell Wall Synthesis InhibitorsBacterial Glycan BiosynthesisCell Wall Polysaccharide BiosynthesisCell Wall Polysaccharide SynthesisCell Wall Synthesis InhibitionPeptidoglycan BiosynthesisTransglycosylation
A series of hydrophobic N'-mono and N',N"-double alkylated derivatives of the glycopeptide antibiotic eremomycin were synthesized by reductive alkylation after preliminary protection of the N-terminal amino group of the peptide backbone. The investigation of the antibacterial activity in vitro showed that N'-C10H21- and N'-p-(p-chlorophenyl)benzyl derivatives of eremomycin are the most active against vancomycin-resistant enterococci among the compounds obtained though they are less effective than the corresponding lipophilic derivatives of vancomycin. The introduction of two hydrophobic substituents led to a decrease in activity against both susceptible and resistant bacteria. The biochemical evaluation of the mode of action revealed that in addition to binding to D-Ala-D-Ala these compounds also have an alternative mechanism of action that does not require substrate binding.
10
Robert C. Goldman, Eugene R. Baizman, Clifford Longley et al. · FEMS Microbiology Letters · 2000 · 66 citations · Full text